Skip to content

Prospective randomized controlled study of ultrasound-guided microwave ablation in the treatment of adenomyosis

Prospective randomized controlled study of ultrasound-guided microwave ablation in the treatment of adenomyosis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053582
Enrollment
Unknown
Registered
2021-11-24
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Adenomyosis

Interventions

Group 1:Microcatheter balloon intrauterine cooling combined with microwave ablation
Group 2:Traditional microwave ablation

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Females aged 18-45 years; 2. Ultrasound or MRI to diagnose adenomyosis; 3. Positive clinical symptoms: dysmenorrhea, heavy menstrual flow, chronic pelvic pain or pelvic discomfort, combined with anemia, infertility, etc.; 4. Preoperative evaluation of those who meet the indications for ultrasound-guided microwave ablation; 5. Subjects who were informed of the research content and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who may need a second operation cannot be accepted; 2. Those who have recently had uterine or pelvic infection but have not been controlled; 3. Suspected patients with malignant lesions; 4. Patients who refused to be reviewed as required or lost to follow-up after surgery; 5. Those who are known to be allergic to anesthetics and analgesics; 6. Those with severe systemic disease or coagulation dysfunction who cannot tolerate surgery; 7. History of curettage and hysteroscopic surgery in the past; 8. Those who have received other treatments within the past 6 months.

Design outcomes

Primary

MeasureTime frame
degree of thermal damage to the junction zone;

Secondary

MeasureTime frame
ablation percentage;post-ablation complication;degree of symptomatic relief;quantified blood lose during menstruation;pain score;

Countries

China

Contacts

Public ContactXu Huixiong

Shanghai Tenth People's Hospital

xuhuixiong@126.com+86 18917683519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026